Europe Actinic Keratosis Treatment Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$1,796.9

Forecast, 2030 (US$M)

$2,484.5

CAGR, 2024 - 2030

4.7%

Report Coverage

Europe

Europe actinic keratosis treatment market, 2018-2030 (US$M)

Related Markets

Global Actinic Keratosis Treatment Industry Outlook

North America Actinic Keratosis Treatment Market Outlook

Asia Pacific Actinic Keratosis Treatment Market Outlook

Latin America Actinic Keratosis Treatment Market Outlook

MEA Actinic Keratosis Treatment Market Outlook

Europe actinic keratosis treatment market highlights

The Europe actinic keratosis treatment market generated a revenue of USD 1,796.9 million in 2023.
The market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
In terms of segment, topical was the largest revenue generating therapy in 2023.
Topical is the most lucrative therapy segment registering the fastest growth during the forecast period.

Europe data book summary

Market revenue in 2023	USD 1,796.9 million
Market revenue in 2030	USD 2,484.5 million
Growth rate	4.7% (CAGR from 2023 to 2030)
Largest segment	Topical
Fastest growing segment	Topical
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Topical
Key market players worldwide	Almirall SA, Sun Pharmaceutical Industries, Novartis AG ADR, Galderma Group AG Registered Shares, Biofrontera AG, LEO Pharma, Ortho Dermatologics, Hill Dermaceuticals

Other key industry trends

In terms of revenue, Europe region accounted for 27.0% of the global actinic keratosis treatment market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 2,356.7 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Actinic Keratosis Treatment Market Scope

Actinic keratosis treatment market segmentation & scope

Therapy

Topical

Nucleoside Metabolic Inhibitor

NSAIDs

Immune Response Modifiers

Photoenhancers

Others

Surgery

Photodynamic Therapy

End Use

Hospitals

Private Clinics

Homecare

Other

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Germany

Spain

France

Italy

India

China

Japan

South Korea

Australia

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

UAE

Actinic Keratosis Treatment Market Companies

Name	Profile	# Employees	HQ	Website

Europe actinic keratosis treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to actinic keratosis treatment market will help companies and investors design strategic landscapes.

Topical was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe actinic keratosis treatment market based on topical covering the revenue growth of each sub-segment from 2018 to 2030.

Reasons to subscribe to Europe actinic keratosis treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe actinic keratosis treatment market databook

Our clientele includes a mix of actinic keratosis treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe actinic keratosis treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe actinic keratosis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list